Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Con Kelleher

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 21, 2007
Estimation of a preference-based index from a condition-specific measure: the King's Health QuestionnaireJohn Brazier, Carolyn Czoski-Murray, Jennifer Roberts, et al.
Neurourology and Urodynamics|November 1, 2008
Bladder sensations during filling cystometry are different according to urodynamic diagnosisG Alessandro Digesu, Ramandeep Basra, Vik Khullar, et al.
Neurourology and Urodynamics|July 30, 2008
Long-term benefits of darifenacin treatment for patient quality of life: results from a 2-year extension studyPeter Dwyer, Con Kelleher, Jay Young, et al.
Neurourology and Urodynamics|November 16, 2017
Comparative efficacy and tolerability of solifenacin 5 mg/day versus other oral antimuscarinic agents in overactive bladder: A systematic literature review and network meta-analysisJameel Nazir, Con Kelleher, Samuel Aballéa, et al.
BJU International|March 8, 2008
Clinical relevance of health-related quality of life outcomes with darifenacinPaul Abrams, Con Kelleher, Jasper Huels, et al.
Journal of Endourology|July 16, 2004
Laparoscopic nephroureterectomy for adult incontinence caused by functioning ectopic pelvic kidney draining into vaginaBen Challacombe, Con Kelleher, Tariq Sami, et al.
Journal of Market Access & Health Policy|April 25, 2018
Cost-effectiveness of solifenacin compared with oral antimuscarinic agents for the treatment of patients with overactive bladder in the UKZalmai Hakimi, Con Kelleher, Samuel Aballéa, et al.
European Urology|June 7, 2006
The current and future burden and cost of overactive bladder in five European countriesPenny Reeves, Deb Irwin, Con Kelleher, et al.
Current Medical Research and Opinion|February 2, 2016
Oral pharmacotherapy for overactive bladder in older patients: mirabegron as a potential alternative to antimuscarinicsAdrian Wagg, Victor W Nitti, Con Kelleher, et al.
BJU International|December 26, 2006
Oxybutynin transdermal system improves the quality of life in adults with overactive bladder: a multicentre, community-based, randomized studyPeter Sand, Norman Zinner, Diane Newman, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 21, 2007
Estimation of a preference-based index from a condition-specific measure: the King's Health QuestionnaireJohn Brazier, Carolyn Czoski-Murray, Jennifer Roberts, et al.
Neurourology and Urodynamics|November 1, 2008
Bladder sensations during filling cystometry are different according to urodynamic diagnosisG Alessandro Digesu, Ramandeep Basra, Vik Khullar, et al.
Neurourology and Urodynamics|July 30, 2008
Long-term benefits of darifenacin treatment for patient quality of life: results from a 2-year extension studyPeter Dwyer, Con Kelleher, Jay Young, et al.
Neurourology and Urodynamics|November 16, 2017
Comparative efficacy and tolerability of solifenacin 5 mg/day versus other oral antimuscarinic agents in overactive bladder: A systematic literature review and network meta-analysisJameel Nazir, Con Kelleher, Samuel Aballéa, et al.
BJU International|March 8, 2008
Clinical relevance of health-related quality of life outcomes with darifenacinPaul Abrams, Con Kelleher, Jasper Huels, et al.
Journal of Endourology|July 16, 2004
Laparoscopic nephroureterectomy for adult incontinence caused by functioning ectopic pelvic kidney draining into vaginaBen Challacombe, Con Kelleher, Tariq Sami, et al.
Journal of Market Access & Health Policy|April 25, 2018
Cost-effectiveness of solifenacin compared with oral antimuscarinic agents for the treatment of patients with overactive bladder in the UKZalmai Hakimi, Con Kelleher, Samuel Aballéa, et al.
European Urology|June 7, 2006
The current and future burden and cost of overactive bladder in five European countriesPenny Reeves, Deb Irwin, Con Kelleher, et al.
Current Medical Research and Opinion|February 2, 2016
Oral pharmacotherapy for overactive bladder in older patients: mirabegron as a potential alternative to antimuscarinicsAdrian Wagg, Victor W Nitti, Con Kelleher, et al.
BJU International|December 26, 2006
Oxybutynin transdermal system improves the quality of life in adults with overactive bladder: a multicentre, community-based, randomized studyPeter Sand, Norman Zinner, Diane Newman, et al.
Pageof 4